Cargando…

Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical Methodologies

Multiple myeloma (MM) has an inherent high risk of thromboembolic events associated with patient as well as disease- and treatment-related factors. Previous studies have assessed the association of MM-related thromboembolism using “traditional” Kaplan–Meier (KM) and/or Cox proportional hazard (PH) r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Joshua D., Adams, Val R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934550/ https://www.ncbi.nlm.nih.gov/pubmed/27417604 http://dx.doi.org/10.3390/healthcare4010016

Ejemplares similares

Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple Myeloma
por: Brown, Joshua D., et al.
Publicado: (2016)

Multiple primary tumours: incidence estimation in the presence of competing risks
por: Rosso, Stefano, et al.
Publicado: (2009)

An empirical comparison of time-to-event models to analyse a composite outcome in the presence of death as a competing risk
por: Haushona, Ndamonaonghenda, et al.
Publicado: (2020)

Competing Risks Analysis of Cancer-associated Recurrent Thrombosis, Major Bleeds, and Death in a Geriatric Cohort
por: Brown, Joshua D., et al.
Publicado: (2015)

Crude incidence in two-phase designs in the presence of competing risks
por: Rebora, Paola, et al.
Publicado: (2016)

Impact of the censoring distribution on time-to-event problems in the presence of competing risks
por: Donoghoe, Mark W, et al.
Publicado: (2011)

Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients
por: Barrett, Aisling, et al.
Publicado: (2021)

P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA
por: Alp Kirkizlar, Tugcan, et al.
Publicado: (2023)

Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death
por: Arnesen, Carl Arne Løchen, et al.
Publicado: (2021)

Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations
por: Nab, Linda, et al.
Publicado: (2022)

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
por: Brown, Joshua D., et al.
Publicado: (2018)

Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer‐VTE Registry)
por: Ikeda, Masataka, et al.
Publicado: (2022)

Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real‐world evaluation
por: Baker, Hailey A., et al.
Publicado: (2018)

Developing points‐based risk‐scoring systems in the presence of competing risks
por: Austin, Peter C., et al.
Publicado: (2016)

Introduction to the Analysis of Survival Data in the Presence of Competing Risks
por: Austin, Peter C., et al.
Publicado: (2016)

Respiratory-related death in individuals with incident asthma and COPD: a competing risk analysis
por: Gayle, Alicia V., et al.
Publicado: (2022)

Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis
por: Adrianzen-Herrera, Diego, et al.
Publicado: (2022)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
por: Chakraborty, Rajshekhar, et al.
Publicado: (2021)

Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy
por: Kapoor, Mahima, et al.
Publicado: (2020)

Estimating Counterfactual Risk Under Hypothetical Interventions in the Presence of Competing Events: Crystalline Silica Exposure and Mortality From 2 Causes of Death
por: Neophytou, Andreas M, et al.
Publicado: (2018)

Modeling Survival in Patients With Brain Stroke in the Presence of Competing Risks
por: Norouzi, Solmaz, et al.
Publicado: (2021)

Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting
por: Bouwmeester, Walter, et al.
Publicado: (2019)

Computing Individual Risks Based on Family History in Genetic Disease in the Presence of Competing Risks
por: Nuel, Gregory, et al.
Publicado: (2017)

Venous thromboembolism in multiple myeloma is associated with increased mortality
por: Schoen, Martin W., et al.
Publicado: (2020)

Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis
por: Srkalovic, Gordan, et al.
Publicado: (2005)

Venous thromboembolism in critically ill patients: incidence and risk factors
por: Al-Qahtani, S, et al.
Publicado: (2007)

Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention
por: Zareba, Piotr, et al.
Publicado: (2018)

The Cumulative Incidence and Risk Factors of Recurrent Venous Thromboembolism in the Elderly
por: Aleidan, Fahad A S
Publicado: (2020)

Incident thrombus location and predicting risk of recurrent venous thromboembolism
por: Lidstrom, Sara C., et al.
Publicado: (2022)

Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation Phase
por: Awada, Hussein, et al.
Publicado: (2023)

Validation of discrete time‐to‐event prediction models in the presence of competing risks
por: Heyard, Rachel, et al.
Publicado: (2019)

Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release
por: Gidaro, Antonio, et al.
Publicado: (2022)

Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
por: Freeman, Dilys J, et al.
Publicado: (2011)

Estimating risk of encapsulating peritoneal sclerosis accounting for the competing risk of death
por: Lambie, Mark, et al.
Publicado: (2019)

Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study
por: Shim, Seung-Hyuk, et al.
Publicado: (2021)

Trends in survival from myeloma, 1990–2015: a competing risks analysis
por: Sneyd, Mary Jane, et al.
Publicado: (2021)

The importance of censoring in competing risks analysis of the subdistribution hazard
por: Donoghoe, Mark W., et al.
Publicado: (2017)

The Impact of Venous Thromboembolism on Risk of Death or Hemorrhage in Older Cancer Patients
por: Gross, Cary P., et al.
Publicado: (2007)

Metabolites Associated With the Risk of Incident Venous Thromboembolism: A Metabolomic Analysis
por: Jiang, Xia, et al.
Publicado: (2018)

Incidence and Risk Factors of Recurrent Venous Thromboembolism after Pulmonary Embolism
por: Hwang, Hun-Gyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tubqekuajk5lr27tt0tfv2jhnk